Hims & Hers Health, Inc. earnings per share and revenue
On Nov 03, 2025, HIMS reported earnings of 0.06 USD per share (EPS) for Q3 25, missing the estimate of 0.10 USD, resulting in a -43.56% surprise. Revenue reached 598.98 million, compared to an expected 591.85 million, with a 1.20% difference. The market reacted with a -3.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 632.12 million USD, implying an decrease of -50.00% EPS, and increase of 5.53% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
FAQ
What were Hims & Hers Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Hims & Hers Health, Inc. reported EPS of $0.06, missing estimates by -43.56%, and revenue of $598.98M, 1.2% above expectations.
How did the market react to Hims & Hers Health, Inc.'s Q3 2025 earnings?
The stock price moved down -3.6%, changed from $44.39 before the earnings release to $42.79 the day after.
When is Hims & Hers Health, Inc. expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for Hims & Hers Health, Inc.'s next earnings report?
Based on 15
analysts, Hims & Hers Health, Inc. is expected to report EPS of $0.03 and revenue of $632.12M for Q4 2025.